BlackRock-advised Funds > iShares Trust
iShares U.S. Healthcare ETF
$3.21B
Avg Monthly Net Assets
$3.42B
Total Assets
$50.82M
Total Liabilities
$3.37B
Net Assets
iShares U.S. Healthcare ETF is an Exchange-Traded Fund in iShares Trust
from BlackRock-advised Funds,
based in California,
United States of America.
The fund has one share class
and monthly net assets of $3.21B.
On September 24th, 2024 it reported 110 holdings, the largest
being ELI LILLY AND COMPANY (12.0%), UNITEDHEALTH GROUP INCORPORATED (9.3%) and JOHNSON & JOHNSON (6.7%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| iShares U.S. Healthcare ETF | C000012054 | ARCX | IYH |
Holdings
From latest NPORT-P, filed September 24th, 2024 for period ending July 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 10X GENOMICS INC | Long | Equity-common | US | $1M | 61K | 0.04 |
| ABBOTT LABORATORIES | Long | Equity-common | US | $108M | 1M | 3.21 |
| ABBVIE INC (ABBVIE INC.) | Long | Equity-common | US | $194M | 1M | 5.76 |
| ACADIA HEALTHCARE CO INC (ACADIA HEALTHCARE COMPANY, INC.) | Long | Equity-common | US | $3M | 54K | 0.10 |
| AGILENT TECHNOLOGIES INC (AGILENT TECHNOLOGIES, INC.) | Long | Equity-common | US | $24M | 173K | 0.73 |
| ALIGN TECHNOLOGY INC (ALIGN TECHNOLOGY, INC.) | Long | Equity-common | US | $10M | 44K | 0.30 |
| ALNYLAM PHARMACEUTICALS INC (ALNYLAM PHARMACEUTICALS, INC.) | Long | Equity-common | US | $18M | 75K | 0.53 |
| AMEDISYS INC (AMEDISYS, INC.) | Long | Equity-common | US | $2M | 19K | 0.05 |
| AMGEN INC (AMGEN INC.) | Long | Equity-common | US | $105M | 317K | 3.13 |
| APELLIS PHARMACEUTICALS INC (APELLIS PHARMACEUTICALS, INC.) | Long | Equity-common | US | $2M | 62K | 0.07 |
| AVANTOR INC (AVANTOR, INC.) | Long | Equity-common | US | $11M | 400K | 0.32 |
| AZENTA INC (AZENTA, INC.) | Long | Equity-common | US | $2M | 32K | 0.06 |
| BAXTER INTERNATIONAL INC (BAXTER INTERNATIONAL INC.) | Long | Equity-common | US | $11M | 301K | 0.32 |
| BECTON DICKINSON CO (BECTON, DICKINSON AND COMPANY) | Long | Equity-common | US | $41M | 171K | 1.22 |
| BIO RAD LABORATORIES INC (BIO-RAD LABORATORIES, INC.) | Long | Equity-common | US | $4M | 11K | 0.11 |
| BIO TECHNE CORP (BIO-TECHNE CORPORATION) | Long | Equity-common | US | $7M | 92K | 0.22 |
| BIOGEN INC (BIOGEN INC.) | Long | Equity-common | US | $18M | 86K | 0.54 |
| BIOMARIN PHARMACEUTICAL INC (BIOMARIN PHARMACEUTICAL INC.) | Long | Equity-common | US | $9M | 111K | 0.28 |
| BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY (BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares) | Long | Short-term investment vehicle | US | $49M | 49M | 1.47 |
| BLACKROCK CASH FUNDS TREASURY (BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares) | Long | Short-term investment vehicle | US | $6M | 6M | 0.17 |
| BOSTON SCIENTIFIC CORP (BOSTON SCIENTIFIC CORPORATION) | Long | Equity-common | US | $64M | 867K | 1.90 |
| BRISTOL MYERS SQUIBB CO (BRISTOL-MYERS SQUIBB COMPANY) | Long | Equity-common | US | $57M | 1M | 1.69 |
| BRUKER CORP (BRUKER CORPORATION) | Long | Equity-common | US | $4M | 62K | 0.13 |
| CARDINAL HEALTH INC (CARDINAL HEALTH, INC.) | Long | Equity-common | US | $14M | 144K | 0.43 |
| CATALENT INC (CATALENT, INC.) | Long | Equity-common | US | $6M | 107K | 0.19 |
| CENTENE CORPORATION | Long | Equity-common | US | $24M | 315K | 0.72 |
| CEREVEL THERAPEUTICS HOLDINGS INC (CEREVEL THERAPEUTICS HOLDINGS, INC.) | Long | Equity-common | US | $2M | 41K | 0.05 |
| CERTARA INC (CERTARA, INC.) | Long | Equity-common | US | $1M | 70K | 0.03 |
| CHARLES RIVER LABORATORIES INTERNATIONAL INC (CHARLES RIVER LABORATORIES INTERNATIONAL, INC.) | Long | Equity-common | US | $7M | 30K | 0.22 |
| CHEMED CORP (CHEMED CORPORATION) | Long | Equity-common | US | $5M | 9K | 0.15 |
| CIGNA GROUP THE (THE CIGNA GROUP) | Long | Equity-common | US | $57M | 165K | 1.70 |
| COOPER COS INC THE (THE COOPER COMPANIES, INC.) | Long | Equity-common | US | $11M | 115K | 0.32 |
| DANAHER CORP (DANAHER CORPORATION) | Long | Equity-common | US | $108M | 391K | 3.22 |
| DAVITA INC (DAVITA INC.) | Long | Equity-common | US | $4M | 30K | 0.12 |
| DENTSPLY SIRONA INC (DENTSPLY SIRONA INC.) | Long | Equity-common | US | $3M | 122K | 0.10 |
| DEXCOM INC (DEXCOM, INC.) | Long | Equity-common | US | $16M | 234K | 0.47 |
| DOXIMITY INC | Long | Equity-common | US | $2M | 71K | 0.06 |
| EDWARDS LIFESCIENCES CORP (EDWARDS LIFESCIENCES CORPORATION) | Long | Equity-common | US | $22M | 353K | 0.66 |
| ELANCO ANIMAL HEALTH INC (ELANCO ANIMAL HEALTH INCORPORATED) | Long | Equity-common | US | $4M | 291K | 0.11 |
| ELEVANCE HEALTH INC (ELEVANCE HEALTH, INC.) | Long | Equity-common | US | $73M | 137K | 2.17 |
| ELI LILLY CO (ELI LILLY AND COMPANY) | Long | Equity-common | US | $404M | 502K | 12.00 |
| ENCOMPASS HEALTH CORP (ENCOMPASS HEALTH CORPORATION) | Long | Equity-common | US | $5M | 58K | 0.16 |
| ENOVIS CORP (ENOVIS CORPORATION) | Long | Equity-common | US | $2M | 32K | 0.05 |
| ENVISTA HOLDINGS CORP (ENVISTA HOLDINGS CORPORATION) | Long | Equity-common | US | $2M | 101K | 0.05 |
| EXACT SCIENCES CORP (EXACT SCIENCES CORPORATION) | Long | Equity-common | US | $5M | 108K | 0.15 |
| EXELIXIS INC (EXELIXIS, INC.) | Long | Equity-common | US | $4M | 169K | 0.12 |
| FORTREA HOLDINGS INC (FORTREA HOLDINGS INC.) | Long | Equity-common | US | $1M | 52K | 0.04 |
| GE HEALTHCARE TECHNOLOGIES INC (GE HEALTHCARE TECHNOLOGIES INC.) | Long | Equity-common | US | $21M | 252K | 0.63 |
| GILEAD SCIENCES INC (GILEAD SCIENCES, INC.) | Long | Equity-common | US | $56M | 737K | 1.66 |
| GLOBUS MEDICAL INC (GLOBUS MEDICAL, INC.) | Long | Equity-common | US | $5M | 66K | 0.14 |
| GRAIL INC | Long | Equity-common | US | $238K | 15K | 0.01 |
| HCA HEALTHCARE INC (HCA HEALTHCARE, INC.) | Long | Equity-common | US | $41M | 114K | 1.23 |
| HENRY SCHEIN INC (HENRY SCHEIN, INC.) | Long | Equity-common | US | $5M | 75K | 0.16 |
| HOLOGIC INC (HOLOGIC, INC.) | Long | Equity-common | US | $11M | 136K | 0.33 |
| HUMANA INC (HUMANA INC.) | Long | Equity-common | US | $26M | 71K | 0.76 |
| IDEXX LABORATORIES INC (IDEXX LABORATORIES, INC.) | Long | Equity-common | US | $23M | 49K | 0.69 |
| ILLUMINA INC (ILLUMINA, INC.) | Long | Equity-common | US | $12M | 94K | 0.34 |
| INCYTE CORPORATION | Long | Equity-common | US | $7M | 109K | 0.21 |
| INSPIRE MEDICAL SYSTEMS INC | Long | Equity-common | US | $2M | 18K | 0.07 |
| INSULET CORP (INSULET CORPORATION) | Long | Equity-common | US | $8M | 41K | 0.24 |
| INTRA CELLULAR THERAPIES INC (Intra-Cellular Therapies Inc) | Long | Equity-common | US | $5M | 61K | 0.14 |
| INTUITIVE SURGICAL INC (INTUITIVE SURGICAL, INC.) | Long | Equity-common | US | $93M | 209K | 2.75 |
| IONIS PHARMACEUTICALS INC (IONIS PHARMACEUTICALS, INC.) | Long | Equity-common | US | $4M | 86K | 0.13 |
| IQVIA HOLDINGS INC | Long | Equity-common | US | $26M | 106K | 0.78 |
| JAZZ PHARMACEUTICALS PLC (JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY) | Long | Equity-common | IE | $4M | 36K | 0.12 |
| JOHNSON JOHNSON (JOHNSON & JOHNSON) | Long | Equity-common | US | $225M | 1M | 6.68 |
| LABCORP HOLDINGS INC (LABCORP HOLDINGS INC.) | Long | Equity-common | US | $11M | 50K | 0.32 |
| MASIMO CORP (MASIMO CORPORATION) | Long | Equity-common | US | $3M | 25K | 0.08 |
| MEDPACE HOLDINGS INC (MEDPACE HOLDINGS, INC.) | Long | Equity-common | US | $6M | 15K | 0.17 |
| MEDTRONIC PLC (MEDTRONIC PUBLIC LIMITED COMPANY) | Long | Equity-common | IE | $63M | 785K | 1.87 |
| MERCK CO INC (MERCK & CO., INC.) | Long | Equity-common | US | $169M | 1M | 5.03 |
| MODERNA INC (MODERNA, INC.) | Long | Equity-common | US | $23M | 191K | 0.68 |
| MOLINA HEALTHCARE INC (MOLINA HEALTHCARE, INC.) | Long | Equity-common | US | $12M | 34K | 0.35 |
| NATERA INC (NATERA, INC.) | Long | Equity-common | US | $7M | 67K | 0.20 |
| NEUROCRINE BIOSCIENCES INC (NEUROCRINE BIOSCIENCES, INC.) | Long | Equity-common | US | $8M | 59K | 0.25 |
| ORGANON CO (ORGANON & CO.) | Long | Equity-common | US | $3M | 150K | 0.10 |
| PENUMBRA INC (PENUMBRA, INC.) | Long | Equity-common | US | $4M | 22K | 0.11 |
| PERRIGO CO PLC (PERRIGO COMPANY PUBLIC LIMITED COMPANY) | Long | Equity-common | IE | $2M | 80K | 0.07 |
| PFIZER INC (PFIZER INC.) | Long | Equity-common | US | $102M | 3M | 3.04 |
| PREMIER INC (PREMIER, INC.) | Long | Equity-common | US | $1M | 69K | 0.04 |
| QIAGEN NV (Qiagen N.V.) | Long | Equity-common | NL | $6M | 130K | 0.17 |
| QUEST DIAGNOSTICS INC (QUEST DIAGNOSTICS INCORPORATED) | Long | Equity-common | US | $9M | 66K | 0.28 |
| QUIDELORTHO CORP (QUIDELORTHO CORPORATION) | Long | Equity-common | US | $1M | 31K | 0.04 |
| R1 RCM INC (R1 RCM INC.) | Long | Equity-common | US | $1M | 93K | 0.04 |
| REGENERON PHARMACEUTICALS INC (REGENERON PHARMACEUTICALS, INC.) | Long | Equity-common | US | $67M | 62K | 1.98 |
| REPLIGEN CORP (REPLIGEN CORPORATION) | Long | Equity-common | US | $6M | 33K | 0.16 |
| RESMED INC (RESMED INC.) | Long | Equity-common | US | $18M | 86K | 0.54 |
| REVVITY INC (REVVITY, INC.) | Long | Equity-common | US | $9M | 73K | 0.27 |
| ROIVANT SCIENCES LTD | Long | Equity-common | BM | $2M | 207K | 0.07 |
| ROYALTY PHARMA PLC | Long | Equity-common | GB | $7M | 231K | 0.19 |
| SAREPTA THERAPEUTICS INC (SAREPTA THERAPEUTICS, INC.) | Long | Equity-common | US | $8M | 53K | 0.23 |
| SOLVENTUM CORP (SOLVENTUM CORPORATION) | Long | Equity-common | US | $5M | 82K | 0.14 |
| SOTERA HEALTH CO (SOTERA HEALTH COMPANY) | Long | Equity-common | US | $1M | 73K | 0.03 |
| STERIS PLC (STERIS PUBLIC LIMITED COMPANY) | Long | Equity-common | IE | $14M | 58K | 0.41 |
| STRYKER CORP (STRYKER CORPORATION) | Long | Equity-common | US | $70M | 214K | 2.08 |
| TELEFLEX INC (TELEFLEX INCORPORATED) | Long | Equity-common | US | $6M | 28K | 0.18 |
| TENET HEALTHCARE CORP (TENET HEALTHCARE CORPORATION) | Long | Equity-common | US | $9M | 57K | 0.25 |
| THERMO FISHER SCIENTIFIC INC (THERMO FISHER SCIENTIFIC INCORPORATED) | Long | Equity-common | US | $138M | 226K | 4.11 |
| ULTRAGENYX PHARMACEUTICAL INC | Long | Equity-common | US | $2M | 52K | 0.07 |
| UNITED THERAPEUTICS CORP (UNITED THERAPEUTICS CORPORATION) | Long | Equity-common | US | $8M | 26K | 0.24 |
| UNITEDHEALTH GROUP INC (UNITEDHEALTH GROUP INCORPORATED) | Long | Equity-common | US | $313M | 543K | 9.29 |
| UNIVERSAL HEALTH SERVICES (UNIVERSAL HEALTH SERVICES, INC.) | Long | Equity-common | US | $7M | 34K | 0.22 |
| VEEVA SYSTEMS INC (VEEVA SYSTEMS INC.) | Long | Equity-common | US | $17M | 87K | 0.50 |
| VERTEX PHARMACEUTICALS INC (VERTEX PHARMACEUTICALS INCORPORATED) | Long | Equity-common | US | $76M | 153K | 2.25 |
| VIATRIS INC (VIATRIS INC.) | Long | Equity-common | US | $8M | 704K | 0.25 |
| VIKING THERAPEUTICS INC | Long | Equity-common | US | $4M | 62K | 0.11 |
| WEST PHARMACEUTICAL SERVICES INC (WEST PHARMACEUTICAL SERVICES, INC.) | Long | Equity-common | US | $13M | 43K | 0.39 |
| XAV HEALTH CARE SEP24 | Derivative-equity | US | $146K | – | 0.00 | |
| ZIMMER BIOMET HOLDINGS INC (ZIMMER BIOMET HOLDINGS, INC.) | Long | Equity-common | US | $13M | 121K | 0.40 |
| ZOETIS INC (ZOETIS INC.) | Long | Equity-common | US | $49M | 270K | 1.44 |
Address
iShares Trust
400 Howard Street
San Francisco
California
94105
United States of America
Websites
Directors
Cecilia H. Herbert
Drew E. Lawton
James Lam
Jane D. Carlin
John E. Kerrigan
John E. Martinez
Laura F. Fergerson
Madhav V. Rajan
Richard L. Fagnani
Robert S. Kapito
Stephen Cohen
Transfer Agents
JPMorgan Chase Bank, N.A.
Pricing Services
Bloomberg L.P.
ICE Data Pricing & Reference Data, LLC
LSEG US FIN CORP
Custodians
BofA Securities, Inc.
JPMorgan Chase Bank, N.A.
Shareholder Servicing Agents
N/A
Admins
JPMorgan Chase Bank, N.A.
Brokers
J.P. Morgan Securities LLC
Goldman Sachs & Co. LLC
Jefferies LLC
Citigroup Global Markets Inc.
UBS Securities LLC
Morgan Stanley & Co. LLC
BNP Paribas Securities Corp.
Barclays Capital, Inc.
BofA Securities, Inc.
Societe Generale